Exercise in People With Systemic Sclerosis
NCT05234671 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170
Last updated 2024-10-15
Summary
Raynaud's phenomenon and digital ulceration are two of the most common disease manifestations leading to digital and/or toe pain in systemic sclerosis (SSc). In addition to pain, fatigue has been identified as a key stressor and the most prevalent and debilitating symptom of SSc. Both, affect significantly quality of life (QoL) domains. Pharmacological therapeutic strategies have not been proved sufficiently effective in the management of SSc-induced pain and fatigue. Evidently the effectiveness of non-pharmacological interventions (e.g., exercise, cognitive behavioural therapy) is limited, although for some of them (i.e., exercise) evidence is promising. As yet, the effects of a feasible, long-term, tailored exercise programme on pain and fatigue in people with SSc have not been explored. Therefore, the investigators propose a multicentre (n=5) research clinical trial to assess the effect of a previously established, supervised 12-week combined (aerobic and resistance training) exercise programme on pain and fatigue. The 26-month study will recruit 180 people with SSc that will be allocated randomly to two groups. Group A will perform the exercise programme parallel to standard care and Group B will receive the standard care alone. All participants will be followed for 24-weeks. Results will inform clinical practice and may improve QoL for people with SSc.
Conditions
Interventions
- OTHER
-
Exercise programme
12-week exercise programme. The estimated session's duration of 55 minutes. For the prescription of high intensity interval training (HIIT) and the collection of individualised peak power output (PPO) a baseline peak oxygen uptake on an arm crank ergometer will be performed. Each session will consist of 5 minutes warm up performing light to moderate intensity arm cranking (55-65% PPO), 30-minutes' high intensity interval training (HIIT; 30s 100% PPO/ 30s passive recovery) on an arm crank ergometer. The HIIT protocol will be combined with resistance training (RT) lasting for a total of 15 min.The intensity will be at 75-80% of one repetition maximum. Following each exercise session, patients will undertake a 5 min cool-down period.
Sponsors & Collaborators
-
Leiden University
collaborator OTHER -
Rikshospitalet University Hospital
collaborator OTHER - collaborator OTHER
-
Aristotle University Of Thessaloniki
collaborator OTHER -
University of Campania Luigi Vanvitelli
collaborator OTHER -
Sheffield Hallam University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-01
- Primary Completion
- 2023-09-30
- Completion
- 2024-02-28
Countries
- United Kingdom
Study Locations
More Related Trials
-
Pragmatic Clinical Trials in Scleroderma
NCT03610217 ·Status: UNKNOWN ·Phase: NA
-
Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis
NCT00318188 ·Status: COMPLETED ·Phase: NA
-
Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma
NCT02370784 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis
NCT04744207 ·Status: COMPLETED ·Phase: PHASE2
-
CSL Behring Sclero XIII
NCT02551042 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
NCT05177380 ·Status: UNKNOWN ·Phase: NA
-
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
NCT01743612 ·Status: COMPLETED ·Phase: NA
-
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
NCT06297096 ·Status: RECRUITING ·Phase: PHASE3
-
Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.
NCT05171114 ·Status: COMPLETED ·Phase: NA
-
Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis
NCT01834157 ·Status: UNKNOWN
-
Patients Diagnosed With Scleroderma: Physical Performance and Functionality
NCT07183072 ·Status: RECRUITING
-
Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis
NCT03271320 ·Status: COMPLETED
-
Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic Sclerosis
NCT00843102 ·Status: COMPLETED
-
Platelet Gel in Systemic Sclerosis
NCT00463125 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effects of FT011 in Systemic Sclerosis
NCT04647890 ·Status: COMPLETED ·Phase: PHASE2
-
Online Fatigue Intervention Program for People With Scleroderma
NCT04401943 ·Status: COMPLETED ·Phase: NA
-
Scleroderma Patient-centered Intervention Network (SPIN) Hand Program
NCT03419208 ·Status: COMPLETED ·Phase: NA
-
Western Sweden Systemic Sclerosis Project
NCT07345052 ·Status: RECRUITING
-
Role of Eosinophil in Fibrogenesis of Systemic Sclerosis
NCT03816189 ·Status: COMPLETED
-
Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?
NCT05482594 ·Status: UNKNOWN
-
Development and Prevention of Severe Heart Disease in Systemic Sclerosis
NCT01829126 ·Status: UNKNOWN
-
Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients
NCT03558854 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )
NCT03059979 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Utility of Breath-holding Test in Systemic Sclerosis
NCT04484948 ·Status: COMPLETED ·Phase: NA
-
Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility Study
NCT03092024 ·Status: COMPLETED ·Phase: NA